WR Wealth Planners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.21M Sell
1,567
-140
-8% -$116K 0.39% 38
2024
Q3
$1.51M Sell
1,707
-1
-0.1% -$899 0.42% 42
2024
Q2
$1.55M Sell
1,708
-19
-1% -$15.2K 0.47% 38
2024
Q1
$1.34M Buy
1,727
+61
+4% +$43.4K 0.42% 39
2023
Q4
$971K Sell
1,666
-50
-3% -$29.2K 0.36% 50
2023
Q3
$922K Buy
1,716
+164
+11% +$84.5K 0.35% 49
2023
Q2
$728K Buy
1,552
+652
+72% +$273K 0.28% 62
2023
Q1
$309K Buy
900
+759
+538% +$256K 0.13% 125
2022
Q4
$51.6K Hold
141
0.03% 170
2022
Q3
$45.6K Hold
141
0.03% 169
2022
Q2
$45.7K Hold
141
0.03% 177
2022
Q1
$40.4K Buy
+141
New +$36.3K 0.02% 183

Other funds holding LLY

WR Wealth Planners's LLY Position: Q4 2024 in Review

WR Wealth Planners reduced its Eli Lilly (LLY) stake by 8.2% in Q4 2024, selling an estimated $116K and leaving 1,567 shares worth $1.21M. The position accounts for 0.39% of the portfolio, ranked #38.

WR Wealth Planners first reported a position in LLY in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.55M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • WR Wealth Planners held 1,567 shares of Eli Lilly worth $1.21M as of Q4 2024.
  • WR Wealth Planners sold 140 Eli Lilly shares in Q4 2024, an estimated $116K.
  • Eli Lilly made up 0.39% of WR Wealth Planners's portfolio in Q4 2024, its #38 holding.
  • WR Wealth Planners first reported a position in Eli Lilly in Q1 2022 and has held it in 12 quarters since.
  • WR Wealth Planners's Eli Lilly position peaked at $1.55M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.